ロード中...
Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar
Myanmar is an endemic country for the Japanese encephalitis virus (JEV), and the SA-14-14-2 live-attenuated JEV vaccine was first introduced as a catch-up vaccination campaign in 2017. To determine the effectiveness of vaccination by means of neutralizing antibody titers against JEV, a cross-section...
保存先:
| 出版年: | Vaccines (Basel) |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8227667/ https://ncbi.nlm.nih.gov/pubmed/34072933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9060568 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|